CERT
CertaraDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-11
Current thesis
The positive case is that Certara is simplifying around higher-value MIDD and Clinical Intelligence, had 4Q25 total bookings up to $155.2 million with service bookings up 17% year over year, and can redeploy divestiture proceeds into product innovation and execution while exiting a lower-focus services asset.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +1.5.
What can break
2026 revenue guidance of 0-4% and adjusted EBITDA margin guidance of 30-32% leave limited room for execution misses.
Momentum
9
Value
65
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $6.80 · Bull $9.20 · Bear $4.70
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-09 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-06 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-11
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $9.18
Why
Momentum9 · Δ7d +2.2
Value65 · Δ7d +1.5
Sentiment60 · Δ7d +5.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
9
34% active weight
Current posture
7d trendImproving
Δ7d
+2.2
Δ21d
+6.3
Value
65
32% active weight
Current posture
7d trendImproving
Δ7d
+1.5
Δ21d
-0.8
Sentiment
60
33% active weight
Current posture
7d trendImproving
Δ7d
+5.9
Δ21d
-16.4
Why this grade
Composite grade D. Momentum 9.4 / Value 65.2 / Sentiment 60.4
Fundamentals (TTM)As of 2026-06-09
Fundamentals (TTM)
As of 2026-06-09
Market Cap
$805.83M
Beta
1.48
Shares Out
159.27M
P/E (TTM)
133.8
P/S (TTM)
3.46
P/FCF (TTM)
15.73
Rev YoY
+10.3%
EPS YoY
+211.4%
Gross Margin
+61.4%
Op Margin
+6.3%
Net Debt
$116.24M
Current Ratio
2.09
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology